deltatrials
Completed PHASE2 INTERVENTIONAL 3-arm NCT03069703

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy (PNEUMOVAS)

Multicenter Randomized Controlled Trial Comparing Immunogenicity and Safety of Two Innovative Anti-pneumococcal Vaccine Strategies to Standard Vaccination Regimen in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Invasive Pneumococcal Infection
Interventions PCV13 PPV23 Rituximab
Updated 13 times since 2017 Last updated: Nov 17, 2025 Started: Feb 5, 2018 Primary completion: Nov 24, 2020 Completion: Nov 21, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Invasive Pneumococcal Infection, this trial is completed. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 13 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Apr 2017 – ~Apr 2018 · 12 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Mar 2019 · 3 months · monthly snapshot~Mar 2019 – ~Mar 2020 · 12 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Oct 2021 · 4 months · monthly snapshot~Oct 2021 – ~Jul 2022 · 9 months · monthly snapshot~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2025 · 15 months · monthly snapshot~Dec 2025 – present · 7 months · monthly snapshot

Change History

13 versions recorded

  1. Dec 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Dec 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jul 2022 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Oct 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE2

▶ Show 8 earlier versions

  1. Jun 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE2

  3. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  4. Mar 2019 — Mar 2020 [monthly]

    Recruiting PHASE2

  5. Dec 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  7. Apr 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  8. Apr 2017 — Apr 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Assistance Publique - Hôpitaux de Paris
  • CIC 1417 Cochin-Pasteur
  • EUCLID Clinical Trial Platform
  • Groupe Français d'Etude des Vascularites (GFEV)
  • Recherche Clinique Paris Descartes Necker Cochin Sainte Anne
  • URC-CIC Paris Descartes Necker Cochin
Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations